ES2056149T3 - Ambliommina, una nueva sustancia activa para la terapia anticoagulante. - Google Patents

Ambliommina, una nueva sustancia activa para la terapia anticoagulante.

Info

Publication number
ES2056149T3
ES2056149T3 ES89109770T ES89109770T ES2056149T3 ES 2056149 T3 ES2056149 T3 ES 2056149T3 ES 89109770 T ES89109770 T ES 89109770T ES 89109770 T ES89109770 T ES 89109770T ES 2056149 T3 ES2056149 T3 ES 2056149T3
Authority
ES
Spain
Prior art keywords
ile
glu
leu
gly
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89109770T
Other languages
English (en)
Inventor
Werner Bonin
Paul Habermann
Dominique Tripier
Elisabet Woehner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2056149T3 publication Critical patent/ES2056149T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS ACTIVADORES - AMBLIOMICINA PARA LA TERAPIA DE ANTICOAGULACIONES ASI COMO UN PROCEDIMIENTO PARA SU AISLAMIENTO A PARTIR DE CELULAS ESCUDO LA PROTEINA AISLADA CON EFECTO INHIBIDOR DE LA TROMBINA TIENE UN PESO MOLECULAR DE 20000 A 30000 DALTON, UN PUNTO ISOELECTRICO ENTRE 5.05 Y 5.65 Y UNA SECUENCIA DE AMINOACIDOS COMO SE MUESTRA EN LA FORMULA(I), DONDE CADA RESTO X PUEDE SER IGUAL O DISTINTO Y ES RESPECTIVAMENTE PARA UN AMINOACIDO QUE EXISTE NATURALMENTE.
ES89109770T 1988-06-04 1989-05-30 Ambliommina, una nueva sustancia activa para la terapia anticoagulante. Expired - Lifetime ES2056149T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3819078A DE3819078A1 (de) 1988-06-04 1988-06-04 Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie

Publications (1)

Publication Number Publication Date
ES2056149T3 true ES2056149T3 (es) 1994-10-01

Family

ID=6355878

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89109770T Expired - Lifetime ES2056149T3 (es) 1988-06-04 1989-05-30 Ambliommina, una nueva sustancia activa para la terapia anticoagulante.

Country Status (18)

Country Link
US (1) US5093322A (es)
EP (1) EP0345614B1 (es)
JP (1) JP2703993B2 (es)
KR (1) KR0138531B1 (es)
AT (1) ATE107666T1 (es)
AU (1) AU618364B2 (es)
CA (1) CA1339189C (es)
DE (2) DE3819078A1 (es)
DK (1) DK270489A (es)
ES (1) ES2056149T3 (es)
FI (1) FI93697C (es)
HU (2) HU205148B (es)
IE (1) IE64674B1 (es)
IL (1) IL90508A (es)
NO (1) NO175900C (es)
NZ (1) NZ229401A (es)
PT (1) PT90739B (es)
ZA (1) ZA894181B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385885A (en) * 1988-01-15 1995-01-31 Gasic; Gregory P. Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide
DE3931839A1 (de) * 1989-09-23 1991-04-04 Basf Ag Neue proteine und ihre herstellung
DE4136513A1 (de) * 1991-11-06 1993-05-13 Basf Ag Neues thrombininhibitorisches protein aus raubwanzen
US5321010A (en) * 1991-12-10 1994-06-14 Merck & Co., Inc. Proteins for inhibiting adhesion of platelets to collagen
CA2150909A1 (en) * 1992-12-04 1994-06-23 Christiane Noeske-Jungblut Clotting inhibitor made from protostomia saliva
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US20050033022A1 (en) * 1997-09-26 2005-02-10 Smithkline Beecham Biologicals Sa Fusion proteins comprising HIV-1 Tat and/or Nef proteins
BRPI0406057B1 (pt) * 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
KR102429287B1 (ko) 2015-12-10 2022-08-05 가부시끼가이샤 메니콘 펩티드 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
NO170430C (no) * 1986-09-18 1992-10-14 Pennsylvania Hospital Fremgangsmaate for fremstilling av et protein som har antikoagulerende og anti-metastatiske egenskaper
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
CA2024697A1 (en) * 1989-09-07 1991-03-08 George P. Vlasuk Protein having anticoagulant properties

Also Published As

Publication number Publication date
NO175900C (no) 1994-12-28
EP0345614A2 (de) 1989-12-13
CA1339189C (en) 1997-07-29
FI93697C (fi) 1995-05-26
IE64674B1 (en) 1995-08-23
NZ229401A (en) 1991-10-25
AU618364B2 (en) 1991-12-19
DE3819078A1 (de) 1989-12-07
EP0345614B1 (de) 1994-06-22
FI892690A0 (fi) 1989-06-01
EP0345614A3 (en) 1990-10-10
DK270489A (da) 1989-12-05
JP2703993B2 (ja) 1998-01-26
HUT52117A (en) 1990-06-28
FI93697B (fi) 1995-02-15
DE58907930D1 (de) 1994-07-28
JPH0232100A (ja) 1990-02-01
PT90739B (pt) 1994-10-31
NO892266L (no) 1989-12-05
HU210528A9 (en) 1995-04-28
KR0138531B1 (ko) 1998-04-30
ATE107666T1 (de) 1994-07-15
NO892266D0 (no) 1989-06-02
IL90508A0 (en) 1990-01-18
FI892690A (fi) 1989-12-05
IL90508A (en) 1994-12-29
NO175900B (no) 1994-09-19
DK270489D0 (da) 1989-06-02
IE891814L (en) 1989-12-04
AU3595489A (en) 1989-12-07
US5093322A (en) 1992-03-03
ZA894181B (en) 1990-02-28
PT90739A (pt) 1989-12-29
KR910001040A (ko) 1991-01-30
HU205148B (en) 1992-03-30

Similar Documents

Publication Publication Date Title
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
RU95115239A (ru) Аналог эритропоэтина
ES548048A0 (es) Un procedimiento para la preparacion de derivados purificados de una glicoproteina.
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
PT81991B (pt) Processo para a preparacao de derivados peptidicos, analogos a pepestatina, inibidores darenina e das proteases acidas
MX9203519A (es) Metodo de recombinacion para la produccion de inhibidores de proteasa de serina y secuencias de adn utiles para los mismos.
ES2056149T3 (es) Ambliommina, una nueva sustancia activa para la terapia anticoagulante.
DK610888D0 (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
ES548052A0 (es) Procedimiento para preparar peptidos
HU896448D0 (en) Process for the preparation of anticoagulant peptides
EP0241136A3 (en) Human class 1 heparin-binding growth factor
FI891020A0 (fi) Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi
DE68917536D1 (de) Methode zur Reduktion von aromatischen Amino-Gruppen.
IS3511A7 (is) Fjölpeptíð framleidd með aðferðum líftækninnar, kjarnsýrur sem samsvara þeim, og notkun fjölpeptíðanna sem bóluefnis gegn VHS veiru í fiski
ES504996A0 (es) Un procedimiento para aislar un polipeptido purificado
IT1153208B (it) Procedimento per l'estrazione di sostanze azotate, in particolare proteine e/o amminoacidi da sostanze vegetali, in particolare da sottoprodotti della lavorazione della soia

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 345614

Country of ref document: ES